U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Monday.Shares of argenx SE – ADR (NASDAQ:ARGX) fell sharply in pre-market trading after the company discontinued its Phase 3 UplighTED studies of efgartigimod SC in thyroid eye disease following a futility review.argenx shares dipped 6% to $825.00 in pre-market trading.Here are some other stocks moving lower in pre-market trading.TryHard Holdings Ltd (NASDAQ:THH) shares tumbled 15.2% to $13.16 in pre-market tradin ...

市场整体表现 - 美国股指期货在周一早盘上涨 道指期货上涨约200点 [1] argenx SE – ADR (ARGX) 股价异动 - 公司股价在盘前交易中下跌6%至825.00美元 [1] - 股价下跌主要原因是公司终止了efgartigimod SC治疗甲状腺眼病的3期UplighTED研究 此前一项无效性审查认为该研究不太可能达到主要终点 [1] 其他盘前交易下跌的股票 - TryHard Holdings Ltd (THH) 股价大跌15.2%至13.16美元 此前该股在周五上涨了58% [2] - Site Centers Corp (SITC) 下跌13.4%至6.33美元 [2] - Exicure Inc (XCUR) 下跌8.7%至5.80美元 此前该股在周五上涨了5% [2] - Celldex Therapeutics Inc (CLDX) 下跌8.4%至25.19美元 [2] - CapsoVision Inc (CV) 下跌6.4%至12.03美元 此前该股在周五下跌了约11% [2] - Zillow Group Inc (Z) 下跌5.6%至70.50美元 [2] - BeOne Medicines AG (ONC) 下跌4.9%至303.50美元 [2] - ServiceNow Inc (NOW) 下跌4.7%至824.50美元 此前KeyBanc将其评级下调至“减持” [2] - WaterBridge Infrastructure LLC (WBI) 下跌4.4%至20.05美元 [2] - Pharming Group N V (PHAR) 下跌4.2%至17.23美元 [2]